METHOCARBAMOL description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

METHOCARBAMOL

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

METHOCARBAMOL DESCRIPTION


METHOCARBAMOL




CLINICAL PHARMACOLOGY



Pharmacokinetics:



Special Populations:

Elderly


Renally Impaired


Hepatically Impaired

INDICATIONS & USAGE


CONTRAINDICATIONS

Methocarbamol Tablets are contraindicated in patients hypersensitive to methocarbamol or to any of the tablet components.

WARNINGS


PRECAUTIONS:Pregnancy).

Use in Activities Requiring Mental Alertness:

PRECAUTIONS

Information for Patients:



Drug Interactions:
WARNINGSandPRECAUTIONSfor interaction with CNS drugs and alcohol.


Drug/Laboratory Test Interactions:


Carcinogenesis, Mutagenesis, Impairment of Fertility:


Pregnancy

Teratogenic Effects



WARNINGS).

Nursing Mothers


Pediatric Use

METHOCARBAMOL ADVERSE REACTIONS









www.fda.gov/medwatch.

OVERDOSAGE




Treatment:

DOSAGE & ADMINISTRATION

500 mg Adults: Intial dosage, 3 tablets q.i.d.; maintenance dosage, 2 tablets q.i.d.
750 mg Adults: Intital dosage, 2 tablets q.i.d.; maintenance dosage, 1 tablet q.4h. or 2 tablets t.i.d.

HOW SUPPLIED











STORAGE AND HANDLING



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














METHOCARBAMOL

METHOCARBAMOL

METHOCARBAMOL TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:24236-332(NDC:0143-1290)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
METHOCARBAMOL METHOCARBAMOL 500 mg

Inactive Ingredients

Ingredient Name Strength
METHYLCELLULOSE (100 MPA.S)
lactose monohydrate
STARCH, CORN
SILICON DIOXIDE
MAGNESIUM STEARATE

Product Characteristics

Color Size Imprint Code Shape
white 20 mm West;ward;290 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:24236-332-03 20 in 1 VIAL

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA085159 2013-01-19


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.